Experience

IPMC CNRS - University Nice Sophia Antipolis

• France
• Biotechnology Research
• 1 - 100 Employee

• Chef de groupe de recherche

  • Sep 1999 - Present



institut 3IA Côte d'Azur

• France

• Chaire 3IA Côte d’Azur

  • Jan 2020 - Present



IDEX JEDI Université Côte d’Azur

• Provence-Alpes-Côte d’Azur, France

• coordinateur Académie "Complexité et diversité du vivant"

  • Jul 2014 - Present



Canceropôle Provence-Alpes-Côte d’Azur

• Région SUD, France

• Président

  • Nov 2019 - Present



Vaincre la mucoviscidose

• Civic and Social Organizations
• 1 - 100 Employee

• Président du Conseil Scientifique

  • 2014 - Present



Institut Pharmacologie Moléculaire & Cellulaire

• Directeur de Recherches

  • Nov 1999 - Present



Institut de Pharmacologie Moléculaire et Cellulaire

• Sophia Antipolis, FRANCE

• Directeur

  • Jan 2004 - Dec 2017

  IPMC (18 research groups, 200 people, 8,000 m² of laboratories) is a mixed unit between CNRS and UNS, located in the scientific park of Sophia Antipolis. IPMC investigators have provided many contributions in cellular, molecular & integrative biology. They study key biomolecules in the context of various human pathologies. Their work has indeed contributed to the discovery and development of several new pharmacological approaches, eventually leading to the development of new treatments against human diseases: cancers, neurodegenerative disorders (Alzheimer’s, Parkinson’s), cardiovascular, inflammatory and respiratory diseases, hypertension, obesity, stroke, depression or pain. Neurosciences, pharmacology, cell biology, biochemistry, structural biology, integrative biology, functional genomics and bioinformatics represent important axes of development for our future. My own research team explores the complexity of the RNA world in the context of normal and pathological respiratory tissues. The respiratory tissue frequently harbours proliferation, migration and differentiation of specialized cells that are required for its functionality. Any alteration in the precise cellular choreography can lead to various lung pathologies (cancer, pulmonary fibrosis, cystic fibrosis, chronic obstructive pulmonary disease, asthma,...). During the past years, the importance of different species of RNA to control these processes has been established. Our goal is to characterize the impact of non coding RNAs on cellular fate and define their mode of action using large scale biological approaches (functional genomics, mass spectrometry). Our development includes state-of-the-art approaches in molecular biology, genomics, bioinformatics and RNA biology. Show less



Cancéropôle PACA

• Région de Marseille, France

• Président du Comité Scientifique

  • 2015 - Sep 2017



UCSF Cardiovascular Research Institute

• Visiting Scientist

  • Jan 1998 - Oct 1999